血管紧张素Ⅱ受体2抗体

?血管紧张素Ⅱ受体2抗体Quantity size:

0.2ml

Concentration:

1mg/ml   Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

Angiotensin II (Ang II) is an important physiological effector of blood pressure and volume regulation through vasoconstriction, aldosterone release, sodium uptake and thirst stimulation. Although Ang II interacts with two types of cell surface receptors, AT1 and AT2, most of the major cardiovascular effects seem to be mediated through AT1. 血管紧张素Ⅱ受体2抗体Molecular cloning of the AT1 protein has shown it to be a member of the G protein-associated seven transmembrane protein receptor family. Ang II treatment of cells results in activation of several signal transduction pathways as evidenced by tyrosine phosphorylation of several proteins and induction of others. PLC?is phosphorylated after 30 seconds of treatment with Angiotensin II, indicating this as an early signal transduction event. Ang II treatment also stimulates phosphorylation of Shc, FAK and MAP kinases, and induces MKP-1, indicating stimulation of growth factor pathways. Ang II stimulation through AT1 has been shown to activate the JAK/Stat pathway involving a direct interaction between JAK2 and AT1 as demonstrated by coimmunoprecipitation. 血管紧张素Ⅱ受体2抗体The AT1 receptor has no cytoplasmic kinase domain, but is able to function as a substrate for Src kinases and has several putative phosphorylation sites.

Also known as:

血管紧张素Ⅱ受体2抗体AGTR 2; AGTR2; AGTR-2; AGTR2_HUMAN; angiotensin II receptor type 2; Angiotensin II Type 2; Angiotensin II type-2 receptor; Angiotensin receptor 2; AT 2; AT2; AT2R2 ATGR 2; ATGR2; ATGR-2; MRX 88; MRX88; Type 2 angiotensin II receptor; Type-2 angiotensin II receptor.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Dog, Pig, Horse, Sheep, .

●

Immunogen: KLH conjugated synthetic peptide derived from human angiotensin II receptor type 2.

●

Predicted Molecular Weight: 41kDa.

血管紧张素Ⅱ受体2抗体Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  ICC=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl108Hu01骨保护素(OPG)多克隆抗体Polyclonal Antibody to Osteoprotegerin (OPG)

kl108Mu01骨保护素(OPG)多克隆抗体Polyclonal Antibody to Osteoprotegerin (OPG)

kl108Po01骨保护素(OPG)多克隆抗体Polyclonal Antibody to Osteoprotegerin (OPG)

kl108Ra01骨保护素(OPG)多克隆抗体Polyclonal Antibody to Osteoprotegerin (OPG)

kl109Bo01肌肌酸激酶(CKM)多克隆抗体Polyclonal Antibody to Creatine Kinase, Muscle (CKM)

kl109Ca01肌肌酸激酶(CKM)多克隆抗体Polyclonal Antibody to Creatine Kinase, Muscle (CKM)

kl109Fi01肌肌酸激酶(CKM)多克隆抗体Polyclonal Antibody to Creatine Kinase, Muscle (CKM)

kl109Ga01肌肌酸激酶(CKM)多克隆抗体Polyclonal Antibody to Creatine Kinase, Muscle (CKM)

kl109Hu01肌肌酸激酶(CKM)多克隆抗体Polyclonal Antibody to Creatine Kinase, Muscle (CKM)

kl109Mu01肌肌酸激酶(CKM)多克隆抗体Polyclonal Antibody to Creatine Kinase, Muscle (CKM)

kl109Po01肌肌酸激酶(CKM)多克隆抗体Polyclonal Antibody to Creatine Kinase, Muscle (CKM)

kl109Ra01肌肌酸激酶(CKM)多克隆抗体Polyclonal Antibody to Creatine Kinase, Muscle (CKM)

kl109Rb51肌肌酸激酶(CKM)多克隆抗体Polyclonal Antibody to Creatine Kinase, Muscle (CKM)

kl110Bo01抑瘤素M(OSM)多克隆抗体Polyclonal Antibody to Oncostatin M (OSM)

kl110Hu01抑瘤素M(OSM)多克隆抗体Polyclonal Antibody to Oncostatin M (OSM)

kl110Mu01抑瘤素M(OSM)多克隆抗体Polyclonal Antibody to Oncostatin M (OSM)

kl110Ra01抑瘤素M(OSM)多克隆抗体Polyclonal Antibody to Oncostatin M (OSM)

kl112Bo01β细胞素(βTC)多克隆抗体Polyclonal Antibody to Betacellulin (bTC)

kl112Ga01β细胞素(βTC)多克隆抗体Polyclonal Antibody to Betacellulin (bTC)

kl112Hu01β细胞素(βTC)多克隆抗体Polyclonal Antibody to Betacellulin (bTC)

kl112Mu01β细胞素(βTC)多克隆抗体Polyclonal Antibody to Betacellulin (bTC)

kl112Ra01β细胞素(βTC)多克隆抗体Polyclonal Antibody to Betacellulin (bTC)

kl113Hu01核糖核酸酶T2(RNASET2)多克隆抗体Polyclonal Antibody to Ribonuclease T2 (RNASET2)

kl113Ra01核糖核酸酶T2(RNASET2)多克隆抗体Polyclonal Antibody to Ribonuclease T2 (RNASET2)